These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33575433)

  • 1. Visceral adipose tissue-directed FGF21 gene therapy improves metabolic and immune health in BTBR mice.
    Queen NJ; Bates R; Huang W; Xiao R; Appana B; Cao L
    Mol Ther Methods Clin Dev; 2021 Mar; 20():409-422. PubMed ID: 33575433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF21 gene therapy as treatment for obesity and insulin resistance.
    Jimenez V; Jambrina C; Casana E; Sacristan V; Muñoz S; Darriba S; Rodó J; Mallol C; Garcia M; León X; Marcó S; Ribera A; Elias I; Casellas A; Grass I; Elias G; Ferré T; Motas S; Franckhauser S; Mulero F; Navarro M; Haurigot V; Ruberte J; Bosch F
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29987000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of a fat-directed FGF21 gene therapy in aged female mice.
    Anderson JM; Arnold WD; Huang W; Ray A; Owendoff G; Cao L
    Gene Ther; 2024 Mar; 31(3-4):95-104. PubMed ID: 37699965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
    Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
    Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.
    Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A
    Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Visceral Fat by Intraperitoneal Delivery of Novel AAV Serotype Vector Restricting Off-Target Transduction in Liver.
    Huang W; Liu X; Queen NJ; Cao L
    Mol Ther Methods Clin Dev; 2017 Sep; 6():68-78. PubMed ID: 28702474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
    Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
    Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms.
    Satoh A; Han SI; Araki M; Nakagawa Y; Ohno H; Mizunoe Y; Kumagai K; Murayama Y; Osaki Y; Iwasaki H; Sekiya M; Konishi M; Itoh N; Matsuzaka T; Sone H; Shimano H
    iScience; 2020 Mar; 23(3):100930. PubMed ID: 32151974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21.
    Porter JW; Rowles JL; Fletcher JA; Zidon TM; Winn NC; McCabe LT; Park YM; Perfield JW; Thyfault JP; Rector RS; Padilla J; Vieira-Potter VJ
    J Endocrinol; 2017 Nov; 235(2):97-109. PubMed ID: 28765264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF21 induced by carbon monoxide mediates metabolic homeostasis via the PERK/ATF4 pathway.
    Joe Y; Kim S; Kim HJ; Park J; Chen Y; Park HJ; Jekal SJ; Ryter SW; Kim UH; Chung HT
    FASEB J; 2018 May; 32(5):2630-2643. PubMed ID: 29295856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance.
    Bernardo B; Lu M; Bandyopadhyay G; Li P; Zhou Y; Huang J; Levin N; Tomas EM; Calle RA; Erion DM; Rolph TP; Brenner M; Talukdar S
    Sci Rep; 2015 Jul; 5():11382. PubMed ID: 26153793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
    Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
    Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.